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Background: Although numerous studies of the anticancer activities of Korean Red Ginseng (KRG) have
been performed, the therapeutic effect of KRG on leukemia has not been fully elucidated. In this study,
we investigated the antileukemia activities of KRG and its cellular and molecular mechanisms.
Methods: An established leukemia tumor model induced by xenografted T cell lymphoma (RMA cells)
was used to test the therapeutic activity of KRG water extract (KRG-WE). Direct cytotoxic activity of KRG-
WE was conﬁrmed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. The immu-
nomodulatory activities of KRG-WE were veriﬁed by immunohistochemistry, nitric oxide production
assay. The inhibitory effect of KRG-WE on cell survival signaling was also examined.
Results: Orally administered KRG-WE reduced the sizes of tumor masses. Levels of apoptosis regulatory
enzymes and cleaved forms of caspases-3 and -8 were increased by this extract. In addition, expression of
matrix metalloproteinase-9, a metastasis regulatory enzyme, was decreased by KRG-WE treatment. The
proportion of CD11cþ cells was remarkably increased in the KRG-treated group compared to the control
group. However, KRG-WE did not show signiﬁcant direct cytotoxicity against RMA cells.
Conclusion: Our results strongly suggest that the KRG might have antileukemia activity through CD11cþ
cell-mediated antitumor immunity.
Copyright  2016, The Korean Society of Ginseng, Published by Elsevier. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Korean Red Ginseng (KRG) has been widely applied as medicine
and for tonifying and refection in Korea, China, and Japan. Recently,
numerous research studies have found that KRG displays anti-
inﬂammatory, antioxidant, antiobesity, antidiabetic, and anti-
cancer effects [1,2]. Of these, the anticancer activity of KRG is one of
the best-studied areas of ginseng research. To date, anticancer and
antitumor activities of KRG water extract (KRG-WE), ﬁne black
ginseng, ginseng berry extract, wild ginseng, and their individual
saponins have been observed in colon, prostate, liver, pancreas,
brain, and stomach cancer cells [3e7]. Apoptotic activities of
ginseng-derived extracts, G-Rg5, G-Rh1, G-Rh2, and G-Rg3,gineering, Sungkyunkwan Universi
College of Veterinary Medicine, C
m1@chonbuk.ac.kr (J.-H. Kim).
ht  2016, The Korean Society of G
d/4.0/).associated with increased levels of caspase 9 and 3 activities have
been demonstrated [3,8]. Antiangiogenesis activity of G-Rp1 was
also found in in vitro and in vivo tests [9]. In addition, red ginseng
acid polysaccharides were found to activate antitumor immunity
mediated by macrophages, natural killer (NK) cells, and cytotoxic T
lymphocytes [10,11].
Although many systemic studies on the anticancer activity of
KRG have been performed, the effect of KRG on leukemia has not
been fully investigated. Indeed, a few papers have reported the
antileukemia effect of orally administered ginseng-derived com-
ponents from Panax quinquefolius, but not from Panax ginseng [12].
Also, most studies have been performed in in vitro conditions with
HL-60, U937, and NB4 cells [13e15]. Since the number of leukemiaty, 2066 Seobu-ro, Suwon 16419, Korea.
honbuk National University, 79 Gobong-ro, Iksan 54596, Korea.
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leukemia activity of KRG and its molecular and cellar mechanisms
using a xenograft mouse model bearing RMA (murine T cell lym-
phoma) cell tumors using water extract of KRG.
2. Materials and methods
2.1. Materials
KRG-WE was provided by Korea Ginseng Cooperation (Daejeon,
Korea). The contents of ginsenosides such as G-Rg1, G-Re, G-Rf, G-
Rh1, G-Rb1, G-Rc, G-Rb2, and G-Rd in this extract are 1.03, 1.21, 1.04,
0.96, 5.19, 2.02, 1.88, and 0.67 (mg/g dry weight), respectively. So-
dium carboxymethylcellulose (Na CMC) and (3-4-5-
dimethylthiazol-2-yl)-2-5-diphenyltetrazolium bromide were ob-
tained from Sigma Chemical Co. (St Louis, MO, USA). Standard
ginsenosides were purchased from Ambo Institute (Daejeon, Ko-
rea). Fetal bovine serum and RPMI1640 were purchased from Gibco
(Grand Island, NY, USA). The RMA cells used in the present exper-
iments were obtained from ATCC (Rockville, MD, USA). All other
chemicals were from Sigma Chemical Co. Total or phospho-speciﬁc
antibodies were purchased from Cell Signaling Technology (Dan-
vers, MA, USA). Anti-CD11c and horse radish peroxidase-labeled
secondary antibodies were acquired from Abcam (Cambridge,
MA, USA) [16e18].
2.2. Cell culture
RMA cells were cultured in RPMI-1640 supplemented with 10%
heat-inactivated fetal bovine serum and 1% antibiotics (penicillin
and streptomycin) at 37C under 5% CO2 [19,20].
2.3. Drug treatment
For in vivo experiments, KRG-WE was suspended in 0.5% Na
CMC. For the in vitro cytotoxicity test, KRG-WE was suspended in
100% DMSO at a concentration of 100 mg/mL, and the solution was
ﬁltered before dilution with culture medium, as reported previ-
ously [21].
2.4. Xenograft mouse model experiments
All animal experiments were carried out in accordance with the
National Research Council’s Guide for the Care and Use of Labora-
tory Animals (IACUC, Seoul, Korea). The experimental protocol was
approved by the Animal Experiments Committee of Sungkyunkwan
University. C57BL/6 mice (male, age 5 wks; Orient, Sungnam, Ko-
rea) were used as our xenograft animal model. Mice were housed
individually on a 12-h day/12-h night cycle at 23e27C and had free
access to food and water. Mice were randomly divided into two
groups (n¼ 14/group): (1) a vehicle control group (n¼ 10): animals
received oral administration of 0.5% Na CMC; and (2) a KRG-WE
treatment group (n¼ 14): animals received oral administration of
KRG-WE (20 mg/kg) in Na CMC. To produce tumors, each mouse
was implanted with RMA cells (1106 cells per animal) subcuta-
neously in the back next to the right hind leg [19]. Next, KRG-WE
(20 mg/kg) or vehicle was administered orally from Day 1 to Day
21. On predetermined days, the tumors were identiﬁed and
measured with a standard caliper. Tumor volume was calculated as
follows:
Tumor volume (mm3)¼[tumor length (mm)tumor width
(mm)2]/2. (1)
Mice were sacriﬁced at Day 25.2.5. Cell cytotoxicity
Cytotoxicity of KRG-WE against RMA cells was evaluated by a
conventional (3-4-5-dimethylthiazol-2-yl)-2-5-
diphenyltetrazolium bromide assay as previously described [22].
Brieﬂy, the cells were plated in 96-well plates at a density of 1105
cells/well and treated with different concentrations of KRG-WE
(0 mg/mL, 200 mg/mL, 400 mg/mL, and 800 mg/mL) for 24 h. The
absorbance was measured using a microplate reader at 540 nm.
2.6. Preparation of total lysates from tumor and immunoblotting
Total lysates prepared from cancer tissue were subjected to
western blot analysis of cleaved caspase-3, caspase-8, total form of
matrix metalloproteinase (MMP)-9, and phospho-forms of p85, a
regulatory protein of phosphatidylinositol-4,5-bisphosphate 3-
kinase, and protein kinase B (AKT) and visualized as reported
previously [21,23,24]. Beta-actin was used as a loading control.
2.7. Immunohistochemistry
Parafﬁn-embedded tissue sections of 4-mm thickness were
deparafﬁnized in xylene and rehydrated in phosphate buffered
saline. To block endogenous peroxidase activity, the sections were
incubated in 3% H2O2 solution in methanol at room temperature for
10 min. Subsequently, the slides were preincubated in 10% fetal
bovine serum to prevent nonspeciﬁc binding, and the respective
antibody was applied at 4C overnight. After incubation with the
CD11c antibody, the sections were incubated with biotinylated
horse radish peroxidase-labeled secondary antibody for 10 min.
3,30-Diaminobenzidine substrate solution was applied to reveal the
antibody staining. Lastly, the tissue sections were counterstained
with Gill’s hematoxylin, dehydrated with alcohols, washed in
xylene, and mounted [25,26].
2.8. HPLC analysis
For determination of ginsenosides in KRG-WE, HPLC was con-
ducted as described previously [7].
2.9. Statistical analysis
All data presented in this paper are the mean standard devi-
ation of an experiment performed with 14 mice (in vivo studies) or
six replicates (in vitro studies). For statistical comparisons, these
results were analyzed using ManneWhitney U tests. A p val-
ue< 0.05 was considered statistically signiﬁcant. All statistical tests
were carried out using the computer program SPSS (version 22.0,
2013; IBM Corp., Armonk, NY, USA).
3. Results and discussion
To conﬁrm the anticancer activity of KRG, a xenograft mouse
model bearing RMA cell-derived tumors was constructed as re-
ported previously [19]. Injected RMA cells, a subline of the Raucher
virus-induced T cell lymphoma RBL-5 (H-2b) [20], efﬁciently
generated tumor tissues in mice (Fig. 1). The tumors in the group
with orally administrated KRG-WE (20 mg/kg) were minuscule
compared to those of the control group (Fig. 1A), and the excised
cancer tissues from the mice were also smaller (Figs. 1B and 1C).
These results implied that orally administrated KRG-WE might
have antileukemia activity. Various wild, cultivated, and processed
forms of ginseng have been reported to have anticancer activity
in vivo against hepatocellular carcinoma, Lewis lung carcinoma
(LLC-1), and SW480 human colon cancer cells [27e31]. In addition,
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Fig. 1. Anticancer activity of Korean Red Ginseng water extract (KGR-WE) in a xenograft mouse bearing RMA cell-derived tumors. (A) RMA cells (1106 cells per mouse) were
injected subcutaneously into the back of mice next to the right hind leg, and the mice were orally administered Korean Red Ginseng (20 mg/kg) or vehicle for 3 wks. The induced
tumors were identiﬁed and the size of the mass was measured on the indicated days. (B) Photograph of xenograft mice bearing RMA cell-derived tumors. (C) The excised tumor
tissues were measured (right panel) and photographed (left panel) at Day 21. * p< 0.05 and ** p< 0.01 compared with the control.
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displayed clear antileukemia activity [7]. Therefore, the present and
previous data strongly suggest that ginseng could be a useful herbal
medicine for the prevention and treatment of various types of
cancers including leukemia, colon cancer, and hepatoma. Indeed,
several clinical trials with colon and gastrointestinal cancer pa-
tients have demonstrated the effectiveness of ginseng in thera-
peutic approaches [32,33].
Since a reduced tumor size was observed in the mice treated
with KRG-WE, we next examined the mechanism contributing to
the inhibition of tumor tissue expansion. The levels of proteins
related to cell death and survival, cleaved caspases-3 and -8, MMP-
9, phospho-p85, and phospho-AKT, were determined by immu-
noblot analysis with antibodies speciﬁc for total protein and for the
cleaved and phospho-proteins that represent the active forms
[21,23,24]. The levels of cleaved forms of caspases-3 and -8 were
signiﬁcantly increased and the level of total MMP-9 in the KRG-WE
group was remarkably decreased in the KRG-WEetreated group
compared to the control group (Fig. 2A). Unexpectedly, the levels of
phospho-forms of p85 and AKT, which are involved in survival
signaling [34], were increased in the KRG-WE-treated group
(Fig. 2B). From these results, we assumed that the anticanceractivities of KRG-WE are not derived from the direct induction of
cytotoxicity through apoptosis but instead are acquired through the
stimulation of immune cells such as dendritic cells, neutrophils,
and macrophages. To determine whether KRG-WE affects the
stimulation of immune cells, we performed immunohistochemical
analysis of cancer tissue sections using anti-CD11c antibody. CD11c
is a well-known surface molecule expressed in innate immune cells
such as macrophages, monocyte, dendritic cells, and neutrophils
[35]. As shown in Fig. 3, the proportion of CD11cþ cells was
remarkably increased in the KRG-WE treated group compared with
the control group. To conﬁrm these data, an in vitro cell prolifera-
tion assay was also performed to determine whether KRG-WE
directly suppressed the proliferation of RMA cells. As expected,
there was no signiﬁcant cytotoxic effect on RMA cell proliferation
under treatment with KRG-WE (even at 400 mg/mL and 800 mg/mL;
Fig. 4). Based on the results, we propose that KRG-WE decreases the
size of tumor tissue through the recruitment of immune cells and
subsequent induction of apoptotic signaling. Exactly how the
recruited immune cells arrest the growth of tumor cells is not yet
understood. Therefore, we will further explore the suppressive
mechanism of KRG-WE on the growth of leukemia cells in vivo in
future studies.
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Fig. 4. Effect of Korean Red Ginseng water extract (KGR-WE) on the viability of RMA
cells. (3-4-5-dimethylthiazol-2-yl)-2-5-diphenyltetrazolium bromide assay was
conducted to determine the dose-dependent viability of RMA cells treated with
KGR-WE for 24 h. **p< 0.01 compared with the control group.
A B
Fig. 2. Effect of KoreanRedGinsengwater extract (KGR-WE) on the expressionof proteins involved in apoptotic cell death and survival pathways. Levels of cleaved (C)-caspases-3 and8,
total form of matrix metalloproteinase (MMP)-9, phospho-forms of protein kinase B (p-AKT), p85, and b-actin in RMA tumor tissues were determined by immunoblotting analysis.
J Ginseng Res 2016;40:431e436434The anticancer activity of ginseng is generally considered to be
due to the regulation of immune cells including macrophages and
NK cells [5,14]. In addition, various components of ginseng, such as
compound K, G-Rh1, G-F2, G-Rg3, and G-Rp1, or ginseng-derived
preparations were identiﬁed as anti-cancer saponins [36e40].
Even though this extract includes these components according to
HPLC analysis (Fig. 5), their anti-cancer activity seems to be mar-
ginal. In fact, the extract had no direct cytotoxicity in an in vitro test
(Fig. 4), and, more importantly, the levels of CD11cþ cells were
increased in tumor tissues (Fig. 3). It was reported that acid poly-
saccharide fractions are able to stimulate cellular responses of
innate immune cells such as macrophages, dendritic cells, and NK
cells [41]. The acid polysaccharides were also shown to activate
these cells to secrete cytotoxic molecules such as nitric oxide and
tumor necrosis factor-a in vitro [10,41]. Indeed, acid poly-
saccharides are reported to account for 74% of total KRG-WE [42].
Considering these ﬁndings, it is possible that the antileukemia ac-
tivity of KRG-WE might be generated by acid polysaccharides. We
will test this possibility through further study.
In summary, KRG-WE has been demonstrated to exhibit strong
anticancer activity in a xenograft mouse model bearing RMA cell-
derived tumors without showing direct cytotoxicity. Immunoblot
analysis indicated that apoptotic signaling components such as
cleaved caspases-3 and -8 were increased and the total form of
MMP-9 was decreased by KRG-WE administration. In addition, the
number of CD11cþ cells was remarkably increased in the KRG-WEeControl KRG-WE (20 mg/kg)
CD11c
Cancer tissue
A
Fig. 3. Effect of Korean Red Ginseng water extract (KGR-WE) on the inﬁltration level of C
chemistry after tissue sectioning. Photographs were taken under microscopy. (B) The cellstreated group compared with the control group. These results
strongly suggest that KRG-WE might have the ability to reduce the
incidence of leukemia through the recruitment of immune cells and
subsequent induction of apoptotic signaling in leukemia cells.0
2
4
6
8
10
C
D
11
c+
(%
 o
f c
an
ce
r t
is
su
e)
**
Vehicle KRG-WE
(20 mg/kg)
B
D11cþ cells. (A) The level of inﬁltrated CD11cþ cells was analyzed by immunohisto-
were counted. * p< 0.05 and ** p< 0.01 compared with the control.
Fig. 5. HPLC proﬁle of Korean Red Ginseng water extract (KGR-WE). Ginsenosides from KGR-WE were identiﬁed.
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